Bumrungrad International Hospital
| تايلاند | تركيا | إسبانيا | |
| العلاج المستهدف لسرطان الرئة | - | من $5,000 / 170,000฿ | من $3,417 / 116,178฿ |
Bookimed لا يضيف رسوماً إضافية على أسعار العلاج المستهدف لسرطان الرئة. الأسعار مأخوذة من قوائم الأسعار الرسمية للعيادات. تدفع مباشرة في العيادة مقابل العلاج المستهدف لسرطان الرئة عند وصولك.
Bookimed ملتزم بسلامتك. نحن نعمل فقط مع المؤسسات الطبية التي تحافظ على معايير دولية عالية في العلاج المستهدف لسرطان الرئة ولديها التراخيص اللازمة لخدمة المرضى الدوليين في جميع أنحاء العالم.
Bookimed يقدم مساعدة خبراء مجانية. منسق طبي شخصي يدعمك قبل وأثناء وبعد العلاج، ويحل أي مشاكل. لن تكون وحيداً أبداً في رحلة العلاج المستهدف لسرطان الرئة.
يتضمن الإجراء إزالة شحمة الرئة ، عادةً لعلاج حالات مثل سرطان الرئة ، وتحسين صحة المريض.
يزيل الإجراء الأورام في الرئتين ، ويساعد في التشخيص ، ويخفف الأعراض بشكل عام ويطيل العمر.
تزيل هذه الجراحة جزءًا صغيرًا على شكل إسفين من أنسجة الرئة ، وذلك في المقام الأول لعلاج سرطان الرئة الموضعي.
اليوم الأول - الوصول
اليوم 2 - ما قبل العملية
اليوم 3 - التحضير للعلاج المستهدف
اليوم 4 - العلاج الهدف
اليوم الخامس - ما بعد العملية
الأسبوع الأول - إعادة التأهيل
الأسبوع 2-4 - إعادة التأهيل
الشهر 2-3 - النتيجة النهائية
يرجى ملاحظة أن عملية الشفاء يمكن أن تختلف تبعًا للظروف الصحية الفردية وكيفية استجابة الجسم للعلاج.
بصفتها المنصة العالمية الرائدة في مجال السياحة الطبية ، يأخذ موقع Bookimed.com على عاتقه مسؤولية تزويد عملائه - المرضى والمراكز الطبية - بمعلومات عالية الجودة تتعلق بالعلاج المستهدف لسرطان الرئة وتايلاند. تستند جميع المعلومات المقدمة على Bookimed.com إلى البحث والاستبصار والخبرة وتفي بالاهتمام الكبير المتعلق بالمنتج.
تشكل Bookimed.com قوائم بالعيادات والأطباء المتعلقة بالعلاج المستهدف لسرطان الرئة في تايلاند مع لوائح صارمة لنظام التصنيف التلقائي الذكي الخاص بنا. يعتمد النظام على أسعار Bookimed الحقيقية للمرضى لتوفير المعلومات الأكثر موضوعية وشفافية حول العيادات والخدمات الطبية هناك.
يجمع عالم البيانات ذو الخبرة في Bookimed.com البيانات يوميًا ، ويراقب ويحسن نظام التصنيف باستخدام التعلم الآلي والذكاء الاصطناعي لضمان تحديث نظام التصنيف وتقديم نتائج دقيقة.
يجمع موقع Bookimed.com آراء المرضى الذين تلقوا علاجًا طبيًا في تايلاند من أجل العلاج المستهدف لسرطان الرئة فقط بعد تجربتهم مع العيادة - لذلك يمكن للجميع على المنصة الوثوق بالمنشأة التي يختارونها. نحن نسعى جاهدين لجعل المحتوى على منصتنا مفيدًا قدر الإمكان ونضمن حرية التعبير عن الآراء النقدية. وبالتالي ، ننشر مراجعات إيجابية وسلبية ، بهدف أن نكون مصدرًا لاتخاذ قرارات مستنيرة لعملائنا في المستقبل.
قد تجد على Bookimed.com الاختيار والراحة للعثور على أفضل الحلول الطبية من كبار مزودي الخدمات الطبية في تايلاند للعلاج المستهدف لسرطان الرئة في مكان واحد فقط ، وغالبًا بأسعار تنافسية. للتأكد من تقديم أحدث المعلومات ، يقوم ممثلو العيادة بتحديث السير الذاتية للأطباء ، وقدرات العيادات ، والصور قبل وبعد ، والأسعار ، والحزم ، والعروض الخاصة بأنفسهم قريبًا. يمكنك مقابلة ممثل العيادة والتحقق من تاريخ المحتوى المحدث في صفحة كل عيادة للتأكد من مصداقيتها.
تم إنشاء مدونة Bookimed.com والقطع الداعمة من قبل مؤلفين محترفين يتمتعون بخبرة لا تقل عن 3 سنوات في الكتابة الطبية ويتم تحريرها من قبل متخصصين طبيين ذوي خبرة سريرية وبحثية ذات صلة - تم تعيينهم جميعًا بعناية في الفريق. نحن نسعى جاهدين لتعزيز وصول المريض إلى المعلومات الصحية المتعلقة بالعلاج المستهدف لسرطان الرئة في تايلاند ، مما يجعله خبيرًا ولكن يسهل فهمه. تتبع جميع القطع إرشادات التحرير الخاصة بـ Bookimed.
نحن مصنوعون من الناس ومن أجلهم - وهذه هي قيمتنا الأساسية. هذا هو السبب في أن جميع البيانات المقدمة على المنصة يتم جمعها وتحريرها ومراجعتها وتحديثها بانتظام من قبل مرضانا وعياداتنا الشريكة وفريقنا ، بما في ذلك المجلس الاستشاري الطبي Bookimed ، الذي يتكون من أطباء مشهورين عالميًا يتمتعون بخبرة قيمة في أكثر من 20 عاما من الممارسة وسمعة طيبة. تعلم المزيد عنا وعن مهمتنا .
في حال وجدت أي خطأ أو كان لديك أي أسئلة حول المعلومات المقدمة على Bookimed.com المتعلقة بالعلاج المستهدف لسرطان الرئة في تايلاند ، فلا تتردد في الاتصال بنا على marketing@bookimed.com .
Targeted therapy for lung cancer is generally safer than chemotherapy because it specifically attacks cancer cells while sparing healthy tissue. Most patients manage side effects well under supervision at Joint Commission International (JCI) accredited facilities like Bumrungrad International Hospital in Bangkok, which serves 1,000,000 patients annually.
Bookimed Expert Insight: Data from top-tier Thai oncology departments shows that comprehensive genetic testing is the most critical safety step. Clinics like Bumrungrad International Hospital utilize advanced digital imaging and AI to monitor drug resistance, which typically occurs after 10-14 months. Knowing the next treatment sequence beforehand significantly improves the patient experience.
Patient Consensus: Many patients find the side effects like skin reactions manageable but emphasize that brain fog and fatigue are often underestimated. Most agree that having a clear plan for drug switches is essential for peace of mind.
To ensure high-quality target therapy for lung cancer in Thailand, prioritize oncologists with Thai Board of Medical Oncology certification and international fellowships. Look for specialists at JCI-accredited facilities like Bumrungrad International Hospital who demonstrate expertise in genomic profiling and NGS testing for specific mutations like EGFR, ALK, or ROS1.
Bookimed Expert Insight: Many patients overlook that top Thai oncologists at Bumrungrad International Hospital often hold dual certifications. With over 50% of their 1 million annual patients coming from abroad, these specialists are uniquely adapted to international protocols. When selecting a doctor, specifically ask for their PubMed publication count regarding targeted therapies to verify their clinical authority.
Patient Consensus: Patients emphasize the importance of choosing communicative specialists who prioritize precision medicine. They often recommend verifying NGS testing capabilities early to ensure the treatment plan aligns with the latest NCCN guidelines.
Comprehensive lung cancer targeted therapy packages in Thailand include advanced biomarker testing for mutations like EGFR or ALK and personalized drug protocols. These programs bundle oncology consultations, diagnostic imaging, and pharmacy services to precisely attack cancer cells while minimizing damage to healthy tissue.
Bookimed Expert Insight: Data from top-tier centers like Bumrungrad International Hospital shows a significant focus on international coordination. While basic packages cover initial drug cycles, patients should confirm if newer generation agents are stocked. Some advanced therapies cost 200,000 to 400,000 THB monthly and may require separate billing. Always verify if the package price includes these specific high-cost medications before starting.
Patient Consensus: Patients emphasize requesting an itemized list of included drugs to avoid unexpected costs. Many noted that genetic testing can add 2 to 4 weeks to the timeline.
Patients typically stay in Thailand for 14 to 21 days during the initial phase. This timeframe allows for essential genetic marker testing, specialist consultations at JCI-accredited facilities like Bumrungrad International Hospital, and monitoring after the first treatment cycle to manage any immediate side effects safely.
Bookimed Expert Insight: Data from Bumrungrad International Hospital shows that 50% of their 1 million annual patients are international. Because they use advanced digital imaging and EHRs, patients can often coordinate biopsy results remotely. This often reduces the first physical trip from 3 weeks down to 10 days.
Patient Consensus: Many patients recommend planning a minimum 2-week first trip for testing and setup. They emphasize confirming if your specific therapy is oral or IV before booking travel to avoid stay extensions.
Thailand is an ideal destination for lung cancer targeted therapy due to its JCI-accredited oncology centers and internationally trained specialists. Facilities like Bumrungrad International Hospital combine advanced molecular testing with significant cost advantages. Patients access cutting-edge drug protocols and personalized precision medicine within high-tech, patient-centric environments.
Bookimed Expert Insight: While Thailand offers world-class care, data suggests using it as a cost-effective treatment hub rather than a primary diagnostic center. You should secure your mutation testing at home first to ensure the Thai protocol matches your specific cancer profile. This cross-verification prevents delays once you arrive in Bangkok.
Patient Consensus: Patients value the significant savings on expensive medications but warn about the difficulty of transferring medical records back home. It is essential to secure all English-language treatment plans and imaging results before your departure to ensure seamless follow-up care.
Targeted therapy for lung cancer in Thailand is predominantly an outpatient procedure. Patients typically receive oral medications to take at home or undergo intravenous infusions in specialized oncology clinics. Hospitalization is rarely required unless initial doses need intensive monitoring for potential allergic reactions or complex combination treatments.
Bookimed Expert Insight: Data from major Bangkok centers shows a shift toward home-based care for EGFR-mutant lung cancer. While surgery may cost between $18,000 and $32,000, targeted therapy avoids high room charges. Many international patients successfully manage their entire treatment cycle from a nearby hotel rather than a hospital bed.
Patient Consensus: Patients value the convenience of `day procedures` where they receive infusions and return to their hotel immediately. It is frequently recommended to arrange a driver for the first visit in case of post-infusion fatigue.
Oncologists in Thailand determine eligibility for targeted lung cancer therapy through molecular biomarker testing and genetic tumour analysis. Specialists at JCI-accredited centres like Bumrungrad International Hospital identify specific mutations, such as EGFR or ALK. This confirms the cancer responds to precision drugs.
Bookimed Expert Insight: Thai oncology centres specialise in EGFR mutations, which appear in 50% of Asian non-smokers with lung cancer. Leading facilities like Bumrungrad International Hospital use telemedicine to review pathology reports before patients fly. This can save weeks of waiting for diagnostic results in Bangkok.
Patient Consensus: Tests in Thailand are thorough. Doctors identify the specific mutations that drive the cancer. Bringing previous pathology results speeds up the process. The staff focus on finding the most precise treatment plan for each case.
When lung cancer resists targeted therapy in Thailand, specialists pivot to next-line protocols. These follow Pan-Asian ESMO guidelines. This process involves repeat biomarker testing to identify new mutations. Doctors then switch to drugs like third-generation TKIs, platinum-doublet chemotherapy, or stereotactic radiation.
Bookimed Expert Insight: Thailand is a regional leader with 150+ clinics specialising in targeted therapy. Leading facilities like Bumrungrad International Hospital serve over 500,000 international patients annually. This volume means oncologists have seen virtually every resistance pattern. This includes secondary T790M mutations and small cell transformations.
Patient Consensus: Patients find that resistance is often detected on routine scans before symptoms appear. Keeping digital records of pathology helps Thai teams act quickly if drugs change. Continuity of care is essential. Confirm that second-line drugs are available before travelling.
Targeted therapy for lung cancer is a precision medicine. It blocks specific genetic mutations, such as EGFR or ALK, that drive tumour growth. Unlike chemotherapy, which kills all rapidly dividing cells, targeted drugs spare healthy tissue to minimise side effects.
Bookimed Expert Insight: While chemotherapy is standard, high-volume centres in Bangkok perform molecular testing for EGFR, ALK, and ROS1 mutations. Bumrungrad International Hospital serves over 500,000 international patients annually. This scale means their labs have the experience needed to identify rare biomarkers.
Patient Consensus: Patients in Thailand found that targeted therapy felt less aggressive than traditional chemo. They suggest requesting all molecular pathology reports in English to help with future care.
Targeted therapy in Thailand is only suitable for non-small cell lung cancer (NSCLC) with specific genetic mutations. It is not an option for small cell lung cancer (SCLC). Suitability requires biomarker testing to identify drivers like EGFR, ALK, or ROS1 before starting treatment.
Bookimed Expert Insight: Targeted drugs are available at 150+ Thai clinics. High-volume centres like Bumrungrad handle 500,000+ international patients yearly. Their scale provides immediate access to molecular testing and drug varieties that smaller clinics often lack.
Patient Consensus: Patients find that full molecular profiling in Thailand is essential for a clear plan. They value the kind, helpful staff and the ability to continue monitoring through telemedicine once they return home.
Thailand's leading oncology centres for targeted therapy include Bumrungrad International Hospital, Wattanosoth Cancer Hospital, and MedPark Hospital. These Bangkok-based facilities specialise in molecular diagnostics for EGFR and ALK mutations. They hold JCI accreditation and provide high-quality care for patients with lung cancer.
Bookimed Expert Insight: Bumrungrad International Hospital serves over 500,000 international patients annually. It holds Global Healthcare Accreditation (GHA). This certification ensures their processes are purpose-built for foreign patients. This makes logistics and medical record transfers much smoother for those travelling from Australia.
Patient Consensus: Fast molecular testing and accessing the right oncologist are more important than hospital amenities. Patients in Thailand suggest bringing all existing pathology and imaging reports to avoid treatment delays.
Targeted therapy in Thailand is given as daily oral tablets or via intravenous infusions at a specialist oncology centre. Delivery depends on genetic mutations found through molecular profiling. Most patients attend outpatient clinics for monitoring while staying in nearby serviced apartments.
Bookimed Expert Insight: Bumrungrad International Hospital serves over 1,000,000 patients annually with half coming from overseas. This massive international volume means their oncology teams are highly efficient. They coordinate with Australian GPs to keep long-term treatment plans consistent once the patient returns home.
Patient Consensus: Patients find the coordination teams very helpful and punctual during their stay in Thailand. Most recommend confirming whether therapy is oral or intravenous before travel to plan accommodation properly.